Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer

NCT01442974 is registered in ClinicalTrials.gov with Grupo Hospital de Madrid as lead sponsor.

NCT NCT01442974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01442974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer
Lead sponsor
Grupo Hospital de Madrid
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2011
Completion date
June 30, 2012
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer